GS
Gudelli Supriya Patak
About Gudelli Supriya Patak
Data last updated:
Gudelli Supriya Patak is a Director at Cns Labs Private Limited (since 2015) and Director at Raabta Pharma Private Limited (since 2018). The companies operate in Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹14.14 Cr; the largest is Cns Labs Private Limited at ₹13.64 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cns Labs Private Limited U24100TG2012PTC083810 | Director | 02 Jul 2015 | 2012 | ₹13.64 Cr (FY 2023) | Active |
 Raabta Pharma Private Limited U24236TG2018PTC126275 | Director | 23 Aug 2018 | 2018 | ₹50.3 Lakh (FY 2022) | Active |
Board colleagues of Gudelli Supriya Patak
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lavanya Pothireddy | 06392277 | Cns Labs Private Limited | Director |
| Yadamakanti Madhu Sudhan Reddy | 02874260 | Cns Labs Private Limited | Director |
| Pusati Bhaskar Reddy | 08205908 | Raabta Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gudelli Supriya Patak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gudelli Supriya Patak
Gudelli Supriya Patak currently holds 2 directorships: Cns Labs Private Limited (Director, since 02 Jul 2015, revenue ₹13.64 Cr (FY 2023)); Raabta Pharma Private Limited (Director, since 23 Aug 2018, revenue ₹50.3 Lakh (FY 2022)).
Gudelli Supriya Patak was first appointed on 02 Jul 2015 as Director at Cns Labs Private Limited. The most recent appointment on record is 23 Aug 2018 at Raabta Pharma Private Limited.
The 2 current companies of Gudelli Supriya Patak that report revenue have a combined latest revenue of ₹14.14 Cr: Cns Labs Private Limited ₹13.64 Cr (FY 2023); Raabta Pharma Private Limited ₹50.3 Lakh (FY 2022).
The current boards of Gudelli Supriya Patak's companies include Lavanya Pothireddy (Cns Labs Private Limited), Yadamakanti Madhu Sudhan Reddy (Cns Labs Private Limited), Pusati Bhaskar Reddy (Raabta Pharma Private Limited).